Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm | 3 | 2012 | 81 | 0.460 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2020 | 98 | 0.460 |
Why?
|
| Stroke Volume | 3 | 2024 | 346 | 0.400 |
Why?
|
| Aneurysm, Infected | 1 | 2012 | 13 | 0.350 |
Why?
|
| Streptococcal Infections | 1 | 2012 | 87 | 0.340 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 131 | 0.320 |
Why?
|
| Myocardial Ischemia | 2 | 2012 | 121 | 0.280 |
Why?
|
| Heart Failure | 3 | 2024 | 968 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 738 | 0.260 |
Why?
|
| Obesity | 2 | 2024 | 1281 | 0.230 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2020 | 118 | 0.220 |
Why?
|
| Echocardiography, Stress | 1 | 2004 | 15 | 0.210 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 35 | 0.210 |
Why?
|
| Rest | 1 | 2004 | 51 | 0.210 |
Why?
|
| Echocardiography | 2 | 2003 | 513 | 0.210 |
Why?
|
| Anthropometry | 1 | 2003 | 86 | 0.190 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 145 | 0.190 |
Why?
|
| Overweight | 1 | 2024 | 254 | 0.180 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2003 | 124 | 0.180 |
Why?
|
| Heart Neoplasms | 3 | 2007 | 36 | 0.180 |
Why?
|
| Bundle-Branch Block | 1 | 2021 | 15 | 0.170 |
Why?
|
| Heart Conduction System | 1 | 2021 | 50 | 0.160 |
Why?
|
| Electrosurgery | 1 | 2020 | 5 | 0.160 |
Why?
|
| Heart Injuries | 1 | 2020 | 19 | 0.160 |
Why?
|
| Papillary Muscles | 1 | 2020 | 16 | 0.160 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2013 | 117 | 0.160 |
Why?
|
| Amyloidosis | 1 | 2021 | 70 | 0.160 |
Why?
|
| Electrocardiography | 2 | 2021 | 556 | 0.150 |
Why?
|
| Mitral Valve | 2 | 2020 | 126 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2020 | 181 | 0.140 |
Why?
|
| Postoperative Complications | 2 | 2004 | 1336 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2021 | 223 | 0.140 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 1117 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 5682 | 0.140 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 171 | 0.130 |
Why?
|
| Aged | 12 | 2024 | 15147 | 0.130 |
Why?
|
| Hemodynamics | 2 | 2016 | 253 | 0.130 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2016 | 4 | 0.120 |
Why?
|
| Male | 15 | 2024 | 31410 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2020 | 5834 | 0.120 |
Why?
|
| Models, Cardiovascular | 1 | 2016 | 84 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2013 | 272 | 0.110 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2016 | 96 | 0.110 |
Why?
|
| Middle Aged | 12 | 2024 | 18501 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 196 | 0.110 |
Why?
|
| Female | 15 | 2024 | 34425 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 284 | 0.110 |
Why?
|
| Heart Ventricles | 2 | 2013 | 267 | 0.100 |
Why?
|
| Humans | 21 | 2024 | 65845 | 0.100 |
Why?
|
| Aortography | 2 | 2012 | 58 | 0.100 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2016 | 226 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6957 | 0.100 |
Why?
|
| Length of Stay | 1 | 2016 | 828 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2016 | 522 | 0.090 |
Why?
|
| Dobutamine | 1 | 2012 | 12 | 0.090 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 226 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 101 | 0.090 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 16 | 0.090 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2012 | 25 | 0.090 |
Why?
|
| Pericardium | 1 | 2012 | 35 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2012 | 122 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2012 | 95 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 171 | 0.080 |
Why?
|
| Exercise Test | 1 | 2012 | 257 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 2500 | 0.080 |
Why?
|
| Recurrence | 1 | 2012 | 665 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 240 | 0.070 |
Why?
|
| Cardiac Tamponade | 1 | 1989 | 14 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 1992 | 367 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 1663 | 0.070 |
Why?
|
| Carcinoid Heart Disease | 1 | 2007 | 1 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2016 | 745 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1569 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 1719 | 0.050 |
Why?
|
| Antiphospholipid Syndrome | 2 | 1995 | 18 | 0.050 |
Why?
|
| Coronary Thrombosis | 1 | 2003 | 21 | 0.050 |
Why?
|
| Embolism, Paradoxical | 1 | 2003 | 14 | 0.050 |
Why?
|
| Heart Rate | 1 | 2004 | 335 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 330 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 859 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2004 | 537 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 326 | 0.040 |
Why?
|
| Prevalence | 1 | 2004 | 1454 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2012 | 491 | 0.040 |
Why?
|
| Tunica Intima | 1 | 1999 | 16 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2020 | 293 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1404 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2016 | 32 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 2 | 1995 | 107 | 0.030 |
Why?
|
| Echocardiography, Doppler | 1 | 2016 | 134 | 0.030 |
Why?
|
| Fibroma | 1 | 1995 | 14 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2016 | 593 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 484 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 488 | 0.030 |
Why?
|
| Child | 2 | 2013 | 4653 | 0.020 |
Why?
|
| Suture Techniques | 1 | 1994 | 97 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1995 | 185 | 0.020 |
Why?
|
| Shear Strength | 1 | 2012 | 20 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1994 | 215 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2012 | 70 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 175 | 0.020 |
Why?
|
| Survival Rate | 1 | 1994 | 849 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1992 | 220 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2116 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 1172 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 3779 | 0.020 |
Why?
|
| Pressure | 1 | 1989 | 80 | 0.020 |
Why?
|
| Infant | 1 | 1994 | 1718 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1992 | 354 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1994 | 2090 | 0.020 |
Why?
|
| Intestinal Neoplasms | 1 | 2007 | 15 | 0.020 |
Why?
|
| Heart Septum | 1 | 2007 | 57 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5475 | 0.020 |
Why?
|
| Adult | 4 | 1999 | 17579 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1992 | 922 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 310 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1992 | 1235 | 0.010 |
Why?
|
| Adolescent | 1 | 1994 | 6368 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 466 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 993 | 0.010 |
Why?
|
| Takayasu Arteritis | 1 | 1999 | 3 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1999 | 41 | 0.010 |
Why?
|
| Marfan Syndrome | 1 | 1999 | 20 | 0.010 |
Why?
|
| Hematoma | 1 | 1999 | 85 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 108 | 0.010 |
Why?
|
| Chest Pain | 1 | 1999 | 86 | 0.010 |
Why?
|
| Microcirculation | 1 | 1992 | 59 | 0.010 |
Why?
|
| Necrosis | 1 | 1992 | 147 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1992 | 125 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1999 | 2324 | 0.000 |
Why?
|